Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Revenue

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹3,822 Cr₹3,749 Cr₹3,454 Cr₹3,252 Cr₹3,278 Cr

What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Revenue ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹3,822 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹3,822 Cr
Mar2025₹3,749 Cr
Mar2024₹3,454 Cr
Mar2023₹3,252 Cr
Mar2022₹3,278 Cr

How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹3,822 Cr
1.93
Mar2025 ₹3,749 Cr
8.56
Mar2024 ₹3,454 Cr
6.21
Mar2023 ₹3,252 Cr
-0.80
Mar2022 ₹3,278 Cr -

Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹43,009.8 Cr -1.3% 0.2% -6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹459,497.0 Cr 8.1% 9.3% 9% Stock Analytics
DIVIS LABORATORIES ₹294,146.0 Cr 10.5% 18% 51.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,474.0 Cr 2.9% 2.1% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,349.0 Cr -0.1% 16% 14.6% Stock Analytics
CIPLA ₹113,989.0 Cr 1.4% 8.1% -6.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.3%

0.2%

-6%

SENSEX

7%

11.5%

-3.5%


You may also like the below Video Courses